The NAI classification issued by the US FDA is the most sought after and corresponds to the highest level of compliance. At 2.57 pm, Sun Pharma ... impacts of an import alert for its Halol ...
Revenue growth of leading 25 domestic drug firms is expected to moderate to 8-10 per cent in the next fiscal year, rating ...
Drug major Sun Pharma is recalling around 55,000 ... It is the largest market for pharmaceutical products. Advisory Alert: It has come to our attention that certain individuals are representing ...
SBI Multi Asset Allocation Fund - Direct (IDCW-Q) 15.48 100000 0.39 SBI Multi Asset Allocation Fund - Direct (IDCW-M) 15.48 100000 0.39 SBI Multi Asset Allocation ...
Generic drug manufacturer Amman Pharmaceutical Industries has been issued an FDA warning letter after being placed on several import alerts, with inspec ...
Sun Pharmaceutical ... drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing pressure. The company’s ...
The concern by experts has been exhibited in the wake of the limited cure options due to complete reliance on Meglumine antimonite, a decades-old imported drug used as ... by allowing some ...
The U.S. branch of India’s Sun Pharma issued a voluntary recall of more ... The Class II recall, which is what the FDA defines as situations that may cause temporary health consequences or ...
Sun Pharmaceutical Industries Limited has announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi, a clascoterone cream. According to the ...
The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...